Post by Novartis UK

Health and medical journalism does more than report the news. It plays a vital role in translating complex scientific advances into accessible information, encouraging accountability and supporting informed debate across the healthcare system. Novartis UK is proud to be the main partner of the 2026 Medical Journalists’ Association (MJA) Awards, reflecting our belief in the value of a credible, independent press that brings accuracy, balance and scrutiny to conversations about science, medicine and healthcare. Health and medical journalism requires a depth of expertise and scrutiny not easily replicated, and the MJA Awards recognise those who uphold the very highest standards. As Shaun Lintern, Health Editor of The Sunday Times and Chair of the MJA, said: "The support Novartis brings means the MJA can continue to independently champion the very best health and medical journalism. This matters because specialist health journalists can deliver stories and investigations that no one else can and a well-informed public is ultimately to the benefit of everyone in industry whether you are a healthcare provider, pharmaceutical company or individual scientist or clinician. The MJA Awards ensure editors know what a good health story is and hopefully encourages them to keep supporting this invaluable part of any newsroom." When stories are told clearly, independently and backed by evidence, they help to ensure the system responds to the needs of the patients. #NovartisOK UK | May 2026 | FA-11681903

Video Content